CG Oncology, Inc. - Common stock (NQ:CGON)

45.51 +1.95 (+4.48%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Price and Volume

Volume	724,623
Open	43.52
Bid (Size)	44.85 (1,000)
Ask (Size)	48.00 (200)
Prev. Close	43.56
Today's Range	43.05 - 45.56
52wk Range	14.80 - 45.56
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting

November 25, 2025

Two late-breaking podium presentations and three posters continue to demonstrate cretostimogene as a potential backbone therapy for a broad range of NMIBC patients

From CG Oncology Inc.

Via GlobeNewswire

This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗

November 17, 2025

A science-first biotech fund just sized up its stake in an ALS-focused company heading into a pivotal year for the firm.

Via The Motley Fool

Performance

YTD	+57.1%	+57.1%
1 Month	+2.8%	+2.8%
3 Month	+68.4%	+68.4%
6 Month	+78.3%	+78.3%
1 Year	+34.1%	+34.1%

More News

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗

November 17, 2025

Via The Motley Fool

Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗

November 17, 2025

Via The Motley Fool

This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗

November 17, 2025

Via The Motley Fool

CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates

November 14, 2025

From CG Oncology Inc.

Via GlobeNewswire

Why Cg Oncology Stock Rocketed 7% Higher Today ↗

October 08, 2025

Via The Motley Fool

CG Oncology Stock Signals Bullish Momentum Ahead ↗

September 08, 2025

Via Benzinga

CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months

September 05, 2025

From CG Oncology Inc.

Via GlobeNewswire

CG Oncology Completes Enrollment in PIVOT-006

September 03, 2025

From CG Oncology Inc.

Via GlobeNewswire

CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences

August 29, 2025

From CG Oncology Inc.

Via GlobeNewswire

Cg Oncology (CGON) Q2 Loss Widens 93% ↗

August 08, 2025

Via The Motley Fool

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates

August 08, 2025

From CG Oncology Inc.

Via GlobeNewswire

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

July 29, 2025

From CG Oncology Inc.

Via GlobeNewswire

Which stocks are moving before the opening bell on Tuesday? ↗

July 22, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 22, 2025

Via Benzinga

Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock ↗

July 16, 2025

Via Benzinga

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

July 07, 2025

Via Investor Brand Network

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

July 07, 2025

Via FinancialNewsMedia

Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going

June 18, 2025

Via FinancialNewsMedia

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

June 05, 2025

From CG Oncology Inc.

Via GlobeNewswire

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

May 15, 2025

From CG Oncology Inc.

Via GlobeNewswire

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

May 13, 2025

From CG Oncology Inc.

Via GlobeNewswire

Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? ↗

May 04, 2025

Via Benzinga

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

May 01, 2025

From CG Oncology Inc.

Via GlobeNewswire

Frequently Asked Questions

Is CG Oncology, Inc. - Common stock publicly traded?

Yes, CG Oncology, Inc. - Common stock is publicly traded.

What exchange does CG Oncology, Inc. - Common stock trade on?

CG Oncology, Inc. - Common stock trades on the Nasdaq Stock Market

What is the ticker symbol for CG Oncology, Inc. - Common stock?

The ticker symbol for CG Oncology, Inc. - Common stock is CGON on the Nasdaq Stock Market

What is the current price of CG Oncology, Inc. - Common stock?

The current price of CG Oncology, Inc. - Common stock is 45.51

When was CG Oncology, Inc. - Common stock last traded?

The last trade of CG Oncology, Inc. - Common stock was at 11/25/25 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.